FDA approves Abiomed's device to treat cardiac shocks

April 7, 2016 9:09 PM

20 0

The U.S Food and Drug Administration approved Abiomed Inc's heart pump to treat patients who suffer cardiac shock after heart attack or heart surgery, sending its shares up about 4 percent in extended trading.

Cardiac shock is a life-threatening emergency condition where the heart is suddenly unable to pump enough blood and oxygen to support the body's vital organs. The condition is rare, but is often fatal if not treated immediately.

Also read: Bank Hapoalim gets okay to raise dividend to 30 pct of net profit

Read more

To category page